Drugs Made In America Acquisition Corp. - Ordinary Shares

Share · KYG2847J1040 · DMAA (XNAS)

No Price

16.12.2025 20:55

Current Prices from Drugs Made In America Acquisition Corp. - Ordinary Shares

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	DMAA	USD	16.12.2025 20:55	10,36 USD	0,00 USD

Share Float & Liquidity

Free Float 86,31 %

Shares Float 28,93 M

Shares Outstanding 33,52 M

Company Profile for Drugs Made In America Acquisition Corp. - Ordinary Shares Share

Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.

Get up to date insights from finAgent about Drugs Made In America Acquisition Corp. - Ordinary Shares

Company Data

Name Drugs Made In America Acquisition Corp. - Ordinary Shares

Company Drugs Made In America Acquisition Corp. Ordinary Shares

Symbol DMAA

Website https://dmaacorp.com

Primary Exchange

NASDAQ

ISIN KYG2847J1040

Asset Class Share

Sector Financial Services

Industry Shell Companies

CEO Lynn Stockwell

Market Capitalization 347 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 1 East Broward Blvd Suite 700, 33301 Fort Lauderdale

IPO Date 2025-01-27

Ticker Symbols

Name	Symbol
NASDAQ	DMAA

More Shares

Investors who hold Drugs Made In America Acquisition Corp. - Ordinary Shares also have the following shares in their portfolio:

FIDELIT.NATL 20/31 Bond

VA-EO EU.GO.13Y EOA ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog